Marketing-authorisation holder
Braintree Labs
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PIZENSY20G · Solution | Lactitol | United States | Marketed | 2020 |
| PIZENSY10gm · For solution | Lactitol | United States | Not marketed | 2020 |
| SUCLEAR1.6GM/BOT,3.13GM/BOT,17.5GM/BOT,N/A,N/A,N/A,N/A; 3350 N/A,N/A,N/A,210GM,0.74GM,2.86GM,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Magnesium sulfate, N/a, Macrogol, N/a,20mg **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, Potassium chloride, Potassium sulfate, Bicarbonate, Sodium chloride, Sodium sulfate | United States | Not marketed | 2013 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Braintree Labs’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call